🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Research by #PICINetwork members @MackallLab and Zinaida Good Stanford Medicine, with Jay Spiegel and others, could inform the design of next-generation CAR T cell therapies.

Single-cell proteomic profiling of circulating #CART cells in patients treated with CD19-CAR shows that CD4+Helios+ CAR #Treg cells on day 7 after infusion are associated with progressive disease & less severe neurotoxicity in patients with #LBCL. nature.com/articles/s4159…

In collaboration with Parker Institute for Cancer Immunotherapy scientists and 10x Genomics, we wrote a commentary on "Advancing T cell–based cancer therapy with single-cell technologies" just out in Nature Medicine: rdcu.be/cVXK8

To accelerate development of effective T cell therapies for cancer, there's an urgent need to decipher the attributes of the ideal therapeutic T cell Read the Meeting Report from the Parker Institute & 10x Genomics Samantha Bucktrout Parker Institute for Cancer Immunotherapy 10x Genomics nature.com/articles/s4159…

Thanks to STAT for covering our work identifying CAR Treg cells as limiting efficacy, toxicity, and expansion of CD19-CAR in lymphoma. Full article in Nature Medicine here: rdcu.be/cVqVr. statnews.com/2022/10/04/why…

Thanks Teiko for highlighting our work with Jay Spiegel, Bita Sahaf, @MackallLab, David Miklos, and team on defining the role of CAR Treg cells in progression following #CART therapy for lymphoma.

Honored to be interviewed by 10x Genomics to discuss our work with Sneha Ramakrishna , @MackallLab, and Michelle Monje🎗️ 🟦 on GD2-CAR T cell therapy for pediatric brain cancer.

Grateful to CGTLive® to publish this summary of our work with @MackallLab, David Miklos, Bita Sahaf and team that I presented at AACR! cgtlive.com/view/lineage-t…

Humbled and grateful to be selected as a 2023 Bridge Fellow by the Parker Institute for Cancer Immunotherapy to push forward CAR T immunotherapy research. parkerici.org/the-latest/ecr…

Grateful to give an invited talk at the 6th Annual #Treg-Directed Therapies Summit! Please join us in Boston this May 21-23. treg-directed-therapies.com

Boom Capital is hiring a Chief of Staff. 🚀 This is one of our most important hires. You'll liaise with our in-house scientific society and impact every aspect of a VC firm, serving unprecedented ideas, scientists and engineers. Join boomcap.co and apply here:

Our Stanford Center for Cancer Cell Therapy is excited to offer a Postdoctoral Fellow position at the interface between machine learning and T cell therapies: postdocs.stanford.edu/prospective/op…

What an honor to give my first invited talk at #ASH2024. I am so grateful to my mentors Crystal Mackall, Sylvia Plevritis, and David Miklos for enabling me to get here! Dec 8 at 4:30 PM, San Diego Conv. Center, Room 33 Cellular Heterogeneity and Relationship to Clinical Outcomes

So proud of Kelvin Mo to give his first talk at #ASH2024! Session 702 Dec 7 at 4:00 PM Manchester Grand Hyatt San Diego, Grand Hall C Title: CCL8/CCL13-Producing Tumor-Associated Macrophages Linked to Poor Outcomes after CAR T Cell Therapy for LBCL

Very proud of Anne Marijn Kramer to present 2 orals and a poster at #ASH2024, especially our work on CD22-CAR! Session 702 Dec 9 at 2:45 PM San Diego Convention Center, Room 6CF Title: CD22-Directed CAR T Cell Single Cell Multiomic Features Associated with IEC-HS